 |
 |
 |
| 1.
|
Ishida M, Miyamoto M, Naitoh S, Tatsuda D, Hasegawa T, Nemoto T, Yokozeki H, Nishioka K, Matsukage A, Ohki M, Ohta T. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Mol Cell Biol 27: 1348-1355, 2007. |
| 2.
|
Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M. Dysadherin expression as a significant prognostic factor and as a determinant of histological features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol 31: 85-94, 2007. |
| 3. |
Okada K, Hasegawa T, Tajino T, Hotta T, Yanagisawa M, Osanai T, Nishida J, Seki K, Itoi E. Clinical relevance of pathological grades of malignant peripheral nerve sheath tumor: a multi-institution of TMTS study of 56 cases in Northern Japan. Ann Surg Oncol 14: 597-604, 2007. |
| 4. |
Hasegawa T. Histological grading and MIB-1 labeling index of soft-tissue sarcomas. Pathol Int 57: 121-125, 2007. |
| 5. |
Kato S, Takeuchi T, Asano T, Ban Y, Yamada T, Hasegawa T, Yamamoto N. Primitive neuroectodermal tumor of the kidney confirmed by fluorescence in situ hybridization. Scand J Urol Nephrol 41: 75-76, 2007. |
| 6.
|
Hosono A, Yamaguchi U, Makimoto A, Watanabe A, Endo M, Shimoda T, Kaya M, Matsumura T, Sonobe H, Kusumi T, Yamaguchi T, Hasegawa T. Utility of immunohistochemical analysis for cyclooxygenase-2 (COX-2) in the differential diagnosis of osteoblastoma and osteosarcoma. J Clin Pathol 60: 410-414, 2007. |
| 7. |
Maeda T, Tateishi U, Hasegawa T, Ojima H, Arai Y, Sugimura K. Primary hepatic angiosarcoma on co-registered FDG-PET and CT images. Am J Roentogenol 188: 1615-1617, 2007. |
| 8. |
Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20: 749-759, 2007. |
| 9.
|
Hirose T, Shimada S, Tani T, Hasegawa T. Ossifying fibromyxoid tumor: invariable ultrastructural features and diverse immunophenotypic expression. Ultrastruct Pathol 31: 233-239, 2007. |
| 10.
|
Tamura G, Sasou S, Kudoh S, Kikuchi J, Ishikawa A, Tsuchiya T, Hasegawa T. Primitive neuroectodermal tumor of the breast: immunohistochemistry and fluorescence in situ hybridization. Pathol Int 57: 509-512, 2007. |
| 11.
|
Noguchi M, Suzuki T, Kabayama K, Takahashi H, Chiba H, Shiratori M, Abe S, Watanabe A, Satoh M, Hasegawa T, Tagami S, Ishii A, Saitoh M, Kaneko M, Iseki K, Igarashi Y, Inokuchi J. GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Cancer Sci 98: 1625-1632, 2007. |
| 12.
|
Akashi-Tanaka S, Omatsu M, Shimizu C, Ando M, Terada K, Shien T, Kinoshita T, Fujiwara Y, Seki K, Hasegawa T, Fukutomi T. Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy. Breast 16: 482-488, 2007. |
| 13.
|
Hirobe M, Takahashi A, Hisasue S, Kitamura H, Kunishima Y, Masumori N, Iwasawa A, Fujimori K, Hasegawa T, Tsukamoto T. Bone scanning?who needs it among patients with newly diagnosed prostate cancer? Jpn J Clin Oncol 10: 788-792, 2007. |
| 14. |
Mitsuhashi T, Nakayama M, Sakurai S, Fujimura M, Shimizu Y, Ban S, Ogawa F, Hirose T, Ishihara O, Shimizu M. KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate. Ann Diagn Pathol 11:49-54, 2007. |
| 15.
|
Mitsuhashi T, Shimizu Y, Ban S, Ogawa F, Matsutani M, Shimizu M, Hirose T. Anaplastic oligodendroglioma: Characteristic cytological features with minigenistocytes. Acta Cytol 51: 657-660, 2007. |
| 16.
|
Kitamura H, Honma I, Torigoe T, Hariu H, Asanuma H, Hirohashi Y, Sato E, Sato N, Tsukamoto T. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients. Urology 70: 38-42, 2007. |
| 17.
|
Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto T. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. J Urol 178: 692-696, 2007. |
| 18. |
Kitamura H, Honma I, Torigoe T, Asanuma H, Sato N, Tsukamoto T. Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. J Urol 177: 1269-1272, 2007. |
| 19. |
長谷川匡. 軟部腫瘍の診断?病理組織診断. 吉川秀樹編. 最新整形外科学大系20 骨・軟部腫瘍および関連疾患. 東京: 中川書店 pp57-64, 2007. |
| 20. |
松村忠紀、長谷川匡. 19. 骨腫瘍. 診断に役立つ免疫組織化学. 病理と臨床臨時増刊号 25: 192-200, 2007. |
| 21.
|
尾松睦子, 長谷川匡. 私の一推し免疫染色?PDGFR. 検査と技術 35: 148-149, 2007. |
| 22.
|
尾松睦子, 長谷川匡. 病理医から消化器外科医へのメッセージ；標本を大事にする病理のわかる消化器外科医とは. 消化器外科 30: 541-549, 2007. |
| 23.
|
長谷川匡. GISTの予後因子（特集 GIST：基礎から臨床の最前線）. 癌の臨床 53: 487-491, 2007. |
| 24.
|
長谷川匡. 脂肪肉腫（高分化型, 粘液型, 脱分化型）. 整形外科 58: 1234-1235, 2007. |
| 25.
|
長谷川匡. 弧在性線維性腫瘍. 整形外科 58: 1610-1611, 2007. |
| 26.
|
長谷川匡. 遺伝子発現解析およびプロテオーム解析によるGISTの予後因子となるバイオマーカーの開発. 病理と臨床 25: 1278-1279, 2007. |
| 27. |
三橋智子. 総説 病理診断に役立つ免疫組織化学の新しいマーカー 骨・軟部腫瘍の診断への応用 診断病理 24: 21-26, 2007. |
| 28. |
栫井成彦、山田成幸、三橋智子、太田章三. 多房性嚢胞性腎細胞癌と乳頭状腎細胞癌を同一腎に認めた１例. 泌尿器外科 20: 175-178, 2007. |
| 29.
|
栫井成彦，三橋智子，太田章三. 陰嚢内に発症した類上皮嚢腫．泌尿器外科 20: 955-958, 2007. |
| 30.
|
栫井成彦，三橋智子，山田成幸, 太田章三. 甲状腺癌腎転移. 泌尿器外科 20: 1315-1318, 2007. |
| 31.
|
浅沼広子, 東恭吾, 近藤啓, 佐々木文, 尾松睦子, 三橋智子, 山口岳彦, 長谷川匡. 肝膿瘍液中に異型細胞を認めた、後腹膜脱分化型脂肪肉腫の一例. 日臨細胞北海道会報 16: 44-47, 2007. |
|
|
 |
